Drugs / oncolytic adenovirus expressing GMCSF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02143804 | Mar 2014 → Mar 2015 | high grade malignant neoplasm, urinary bladder carcinoma | CG Oncology, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oncolytic adenovirus expressing GMCSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02143804 ↗ |
| Route | Other | “intravesical route” NCT02143804 ↗ |